International Journal of Pharmacy Practice最新文献

{"title":"Exploring community pharmacy services in Gulf Cooperation Council countries: a scoping review.","authors":"Solafa M W Noorsaeed, Hisham Alshammari, Natalie Weir, Amanj Kurdi","doi":"10.1093/ijpp/riaf041","DOIUrl":"https://doi.org/10.1093/ijpp/riaf041","url":null,"abstract":"<p><strong>Introduction: </strong>The role of community pharmacists (CPs) is evolving worldwide. However, evidence on the expanding role of CPs in the Gulf Cooperation Council (GCC) countries remains limited.</p><p><strong>Objective: </strong>This study aimed to describe the type, nature, extent, and/or effectiveness of community pharmacy-based services in GCC countries.</p><p><strong>Eligibility criteria: </strong>All primary studies involving existing, piloted community pharmacy services or services being explored for future implementation in the GCC countries were eligible for inclusion.</p><p><strong>Methods: </strong>Ovid MEDLINE, EMBASE, CINAHL, and Scopus were searched from inception to 6 December 2024. Screening and data extraction were performed by two independent reviewers. Results were narratively synthesized.</p><p><strong>Results: </strong>Overall, 116 studies were included. The majority were from KSA (N = 61, 52.6%) and UAE (N = 38, 32.8%), with none in Oman and Bahrain. Besides the nationally practised dispensing and counselling, tele-pharmacy/E-prescription was implemented nationwide in the UAE and KSA. In some countries, minor ailments management, pregnant and lactating women care, reporting adverse drug reactions, immunization, chronic conditions monitoring, independent prescribing, and health promotion were locally practised by some CPs and under-evaluated. Diabetic education, health screening, and medication therapy management were piloted in some countries and showed promising effectiveness. Humanistic effectiveness was the most assessed outcome (N = 16, 13.8%). The most reported barriers were lack of privacy, time, and training.</p><p><strong>Conclusions: </strong>The review highlighted the expanding role of CPs in the GCC countries while identifying gaps in practice. Policymakers can utilize the findings to develop strategies for improving practice, ensuring national implementation, and maintaining the quality of services.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144247831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An exploration of clinical pharmacy practices in Lao PDR: a national survey of hospital pharmacists.","authors":"Vanlounni Sibounheuang, Surasak Chaiyasong, Wanarat Anusornsangiam","doi":"10.1093/ijpp/riaf016","DOIUrl":"10.1093/ijpp/riaf016","url":null,"abstract":"<p><strong>Objectives: </strong>To explore clinical pharmacy practice among hospital pharmacists in the Lao People's Democratic Republic (Lao PDR).</p><p><strong>Methods: </strong>A cross-sectional study was conducted in 158 hospitals of Lao PDR, surveying hospital pharmacists involved in patient care from January to March 2022. The number of pharmacists providing clinical pharmacy and their practice frequency were assessed. Differences across pharmacist characteristics, hospitals, and areas were examined.</p><p><strong>Key findings: </strong>One hundred thirty-nine hospital pharmacists completed the questionnaire, a response rate of 87.9%. The number of hospital pharmacists per 100,000 population was highest in Xaisomboun and lowest in Savannakhet. The number of pharmacists per 1,000 km² was highest in Vientiane prefecture, and very low in many provinces. Only 12 (1.3%) pharmacists reported training in clinical pharmacy. The most prevalent activities were evaluating drug therapy (96.4%), upholding professionalism (96.4%), and committing professionalism (94.9%). The least prevalent were locating evidence (56.8%), applying knowledge (58.9%), and demonstrating continuing professional development (59.7%). Differences in practices were noted between age, qualification, and hospital types. Current major activities included rational drug use, antibiotic stewardship, and managing adverse drug reactions. Future expectations included diabetes, human immunodeficiency virus, and tuberculosis clinics.</p><p><strong>Conclusions: </strong>Clinical pharmacy services like patient care and pharmacotherapy management are frequently provided, but there is a shortage of trained clinical pharmacists and variability in practices between hospitals and regions. Technical support, training programmes, and a clinical pharmacy framework are needed in Lao PDR.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"316-324"},"PeriodicalIF":1.5,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143763367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A systematic review of pharmaceutical care interventions in patients with rheumatoid arthritis.","authors":"Alana Teles Costa, Hygor Rafael da Silva Lima, Divaldo Pereira de Lyra Júnior, Alfredo de Oliveira Filho, Cristiani Isabel Banderó Walker","doi":"10.1093/ijpp/riaf029","DOIUrl":"10.1093/ijpp/riaf029","url":null,"abstract":"<p><strong>Objectives: </strong>This systematic review aimed to describe the work process of pharmaceutical care provided to patients with rheumatoid arthritis (RA).</p><p><strong>Methods: </strong>A systematic review was undertaken based on a search of six databases. The protocol was registered in PROSPERO (CRD42020133705). The inclusion criteria were randomized clinical trials (RCTs) with pharmaceutical care as an intervention in patients previously diagnosed with RA. Two investigators independently selected the studies, extracted data, and assessed their methodological quality. The RoB 2 tool was used to evaluate the quality of the studies. A narrative synthesis of results was provided.</p><p><strong>Key findings: </strong>A total of 3078 titles were found in the initial search, but only six RCTs, with a total of 337 patients, met the established inclusion criteria. These RCTs had some limitations, and only one had a low risk of bias. In most studies (66.6%), the service performed as an intervention had low complexity, was focused only on health education and did not have an individualized care plan for each patient. Telephone interviews or counseling sessions prevailed. The most evaluated outcome was medication adherence. When the intervention was remote and of shorter duration, the improvement in medication adherence was up to 8% (P < .05), whereas when a pharmacotherapeutic follow-up service was provided, this improvement reached 59% (P = .002). Pharmaceutical intervention was also associated with a significant improvement in beliefs about medications, patient satisfaction, reduced drug-related problems, and the cost of treatment.</p><p><strong>Conclusion: </strong>The pharmaceutical care processes should be adjusted to consider the complexity of treatment and patient profiles to produce tailored care plans.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"243-255"},"PeriodicalIF":1.5,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Determinants of healthcare-seeking behavior from pharmacies and associated out-of-pocket spending: a population-based study from Jordan.","authors":"Rasha M Arabyat, Eman A Hammad, Samah Al-Shatnawi, Haneen A Amawi","doi":"10.1093/ijpp/riaf045","DOIUrl":"https://doi.org/10.1093/ijpp/riaf045","url":null,"abstract":"<p><strong>Objectives: </strong>To identify determinants of healthcare seeking from pharmacies in Jordan using Andersen's healthcare utilization model. Additionally, an analysis of the out-of-pocket (OOP) spending was performed.</p><p><strong>Methods: </strong>An analysis of the Jordan Population and Family Health Survey (JPFHS), a nationally representative survey of Jordanian households, was conducted. Weighted hierarchical multiple logistic regression models were built to specify important variables related to seeking care from pharmacies in Jordan compared to other outpatient healthcare facilities.</p><p><strong>Key findings: </strong>Out of 12,716 respondents, 19.1% reported visiting a pharmacy within the past 4 weeks. The associated average OOP spending was JD17.7, significantly lower than for other outpatient healthcare facilities (JD 24.8). Among predisposing characteristics, females were more inclined to visit a pharmacy compared to males (adjusted odds ratio [AOR] = 1.16; 95% CI: 1.02-1.33). Positive enabling factor included residing in northern (AOR: 1.85; 95% CI: 1.19-2.87) or southern regions (AOR: 3.66; 95% CI: 1.57-8.56) compared to center regions of Jordan. The cost of transportation was a negative enabling factor (AOR: 0.24; 95% CI: 0.15-0.40). Significant need factors that increased the odds of visiting a pharmacy included seeking care for fever/diarrhea (AOR: 1.99; 95% CI: 1.04-3.80). Preventive care/vaccination (AOR: 0.18; 95% CI: 0.05-0.68) decreased the odds of visiting a pharmacy.</p><p><strong>Conclusion: </strong>The geographical location of a pharmacy, as indicated by transportation costs and region, significantly influences visiting patterns. Pharmacies appeared to be convenient and accessible for managing minor ailments and they offer significant potential for cost savings. To enhance pharmacies' contribution to public health, the integration of new services is strongly recommended.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144199056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmaceuticals in drinking water: a scoping review to raise pharmacists' public health and environmental awareness on contamination in groundwater, surface water, and other sources.","authors":"Mandy Coderre, Ann-Sophie Fortin, Louis-David Morency, Juliette Roy, Caroline Sirois","doi":"10.1093/ijpp/riaf038","DOIUrl":"https://doi.org/10.1093/ijpp/riaf038","url":null,"abstract":"<p><strong>Objective: </strong>To summarize knowledge on medications and medication-disinfection byproducts-compounds formed when pharmaceutical contaminants react with disinfectants-found in drinking water and its sources (effluents, surface water, groundwater), aiming to raise awareness and empower pharmacists to implement best practices for improving public health and reducing environmental impact.</p><p><strong>Methods: </strong>A scoping review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. Data were retrieved from Medline and Embase between 2005 and 2023 using keywords related to drinking water, pharmaceutical waste, and water purification. Articles had to focus on human medication use and originate from North America and Europe. Data on types of medications, concentrations found in drinking water or its sources, and types of byproducts were extracted, and a narrative synthesis was written.</p><p><strong>Key findings: </strong>Forty-five articles were included. Among pre-defined classes, antihypertensives, analgesics, antibiotics, and psychotropic medications were most frequently found. The most commonly identified medications included carbamazepine, diclofenac, ibuprofen, and acetaminophen/paracetamol. Traces of medications were present in many water sources, with higher concentrations near pharmaceutical industries. Some medications, like carbamazepine, persist in the environment for extended periods. Although not necessarily found in drinking water, medication-disinfection byproducts can be toxic, and further evidence is required to assess their risk.</p><p><strong>Conclusions: </strong>Many medications are found in drinking water and its sources, highlighting the need for pharmacists to consider their public health impact. Best practices, such as prescribing only when necessary, deprescribing, social/green prescribing, and opting for environmentally friendly alternatives, should be enforced.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144191808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predicting medicine related harm in older adults post discharge: an Australian feasibility study.","authors":"Phu Sabei Shwe, Amy Page, H Laetitia Hattingh, Nikesh Parekh, Khalid Ali, Chakravarthi Rajkumar","doi":"10.1093/ijpp/riaf044","DOIUrl":"https://doi.org/10.1093/ijpp/riaf044","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the feasibility of identifying older patients at risk of medicine-related harm (MRH) at hospital discharge using a MRH risk-prediction tool, follow them up in the community, and identify the incidence and severity of MRH causing readmission to hospital.</p><p><strong>Methods: </strong>Patients who were over 65 years admitted to a general medical ward were recruited 48 hours prior to discharge from two hospitals in Queensland, Australia, 19 October 2020 to 15 March 2021. Ward pharmacists predicted the likelihood of MRH post-discharge and confidence in this decision. Participants were followed up until eight weeks post-discharge; data were extracted from hospital records. An expert panel of five senior clinicians assessed structured case summaries of participants who attended hospital within the follow-up 56-day period to determine MRH. MRH risk was assessed using the PRIME (Prospective study to develop a model to stratify the RIsk of Medication-related harm in hospitalized Elderly patients) tool.</p><p><strong>Key findings: </strong>All 39 patients approached consented; 31 participated in follow-up phone calls. Of these 39, 23 (59%) had one or more readmission within 56 days. Six readmissions in five participants were associated with MRH. Of the MRH, three were definite adverse drug reactions while one was due to medicine non-adherence. MRH was potentially preventable in four cases.</p><p><strong>Conclusion: </strong>Outcomes show it is feasible to recruit and complete follow-up of older patients in the Australian healthcare system to examine the burden of MRH and use of a risk identification tool.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge, attitude, and practice about the environmental impact of pharmaceuticals among hospital pharmacists in Spain: a cross-sectional survey.","authors":"Saioa Domingo-Echaburu, Zuriñe Abajo, Usue Elizondo-Alzola, Juan Francisco Rangel-Mayoral, Almudena Rojas-Albarrán, Vladimir Akhrimenko, Gorka Orive, Unax Lertxundi","doi":"10.1093/ijpp/riaf034","DOIUrl":"https://doi.org/10.1093/ijpp/riaf034","url":null,"abstract":"<p><strong>Objectives: </strong>The environmental impact of pharmaceuticals is an issue of growing concern. We aimed to assess the degree of knowledge, attitude, and practice about the environmental impact of pharmaceuticals among hospital pharmacists in Spain.</p><p><strong>Methods: </strong>A cross-sectional descriptive study was conducted using a self-administered online questionnaire. A total of 149 hospital pharmacists out of 4452 answered the survey, yielding a response rate of 3.3%.</p><p><strong>Key findings: </strong>The results showed good knowledge about carbon footprint of metered dose inhalers and the Spanish medicines take-back scheme, while there was room for improvement in the knowledge in some areas (only 43% of respondents knew the concept \"One Health\"). Although the attitudes towards the issue were positive (average score >8 out of 10 for most questions), environmental criteria are rarely considered when developing drug formularies (11.4%) or drug procurement (14.8%).</p><p><strong>Conclusions: </strong>We believe there is an urgent need to raise awareness and knowledge among hospital pharmacists about the negative environmental impact of pharmaceuticals to tackle this problem.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144179894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mental health support in community pharmacy: inclusion of the lived experience voice in supporting service provision.","authors":"Victoria Stewart, Sara S McMillan, Helena Roennfeldt, Jie Hu, Jack C Collins, Sarira El-Den, Claire O'Reilly, Amanda J Wheeler","doi":"10.1093/ijpp/riaf046","DOIUrl":"https://doi.org/10.1093/ijpp/riaf046","url":null,"abstract":"<p><strong>Objectives: </strong>Community pharmacists, as primary healthcare practitioners, play a crucial role in supporting mental health consumers. They often serve as the first point of contact and see mental health consumers more frequently than other healthcare professionals. While their contributions to mental healthcare are increasingly recognized, insight is emerging about the factors that support pharmacists in providing mental healthcare. The aim of this study was to assess the applicability of a framework for pharmacists, pharmacy staff and consumers' empowerment in mental health.</p><p><strong>Methods: </strong>This study used interview data from pharmacists and mental health consumers who had participated in the Australian PharMIbridge RCT. PharMIbridge pharmacists delivered a person-centred, goal-oriented medication support service to mental health consumers. The qualitative data investigating the experiences of pharmacists (n = 16) and consumers (n = 26) were categorized in relation to the existing framework and inconsistencies or differences discussed to identify new factors.</p><p><strong>Key findings: </strong>Study results supported many aspects of the published framework, with two new factors (prevalence of mental distress and looking beyond the mental illness) suggested for inclusion. Additionally, eight factors were expanded with further nuanced details and experiences from the data and are presented with supporting quotations.</p><p><strong>Conclusions: </strong>This study adds further understanding of the factors that moderate the empowerment of pharmacists and consumers in mental healthcare within community pharmacy settings. The inclusion of consumer perspectives has enriched the framework, which can be further utilized by policymakers and community pharmacists to support targeted primary healthcare responses with mental health consumers.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144150354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient prioritization for pharmaceutical intervention in the hospital setting: a retrospective cross-sectional study.","authors":"Maude Plourde, Chantal Gilbert, Mélanie Noël, Sophie Ruelland, Pierre-Hugues Carmichael, Danielle Laurin","doi":"10.1093/ijpp/riaf033","DOIUrl":"https://doi.org/10.1093/ijpp/riaf033","url":null,"abstract":"<p><strong>Objectives: </strong>Prioritization of patients requiring pharmaceutical intervention is critical given limited resources. Data from pharmacy software could be used to target patients. This retrospective cross-sectional study aimed to describe the method implemented in a hospital care unit to prioritize hospitalized patients and compare the characteristics of those receiving a pharmaceutical intervention and those not. This study also explored the possibility of predicting an intervention using pharmacy software data.</p><p><strong>Methods: </strong>All patients admitted to a hospital care unit between November 2019 and April 2020 were included. Prioritization with the pharmacy software was based on preselected admission diagnoses and by operating an antimicrobial stewardship programme. Medications and patients' characteristics were extracted from the pharmacy software. Pharmaceutical interventions and drug-related problems were collected from medical records. Two machine learning algorithms were used to produce rule-based models for pharmaceutical intervention prediction.</p><p><strong>Key findings: </strong>A total of 850 admissions were included. A medication review following prioritization with the pharmacy software or due to external requests was carried out by clinical pharmacists in 45% of admissions, followed by an intervention in 81% of them. Patients who received an intervention had lower creatinine clearance levels and more regular medications including antibacterials for systemic use, diuretics, and psychoanaleptics. The two resulting interpretable models comprised either 6 or 17 predictors of a pharmaceutical intervention.</p><p><strong>Conclusions: </strong>Pharmacy software data may be used for more efficient prioritization of patients using specific criteria. Rule-based models are promising avenues to help clinical pharmacists systematically identify patients requiring pharmaceutical intervention, but further work is warranted.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144150356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adverse drug reaction enquiries to a hospital drug information service: impact of specialty-based clinical pharmacy practice.","authors":"Jeanie Misko, Matthew Rawlins","doi":"10.1093/ijpp/riaf040","DOIUrl":"https://doi.org/10.1093/ijpp/riaf040","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144136184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}